Industry: Medical Devices & Consumables
Published Date: 2025-07-02
Pages: 146 Pages
Report ld: 4777929
Request Sample
Customized Report
Vertebroplasty and Kyphoplasty Device Market Size(US$)

CAGR 2025-2031
4.6%
Market Size,2031
USD 1,524
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Vertebroplasty and Kyphoplasty Device market is projected to grow from US$ 1163 million in 2025 to US$ 1524 million by 2031, at a Compound Annual Growth Rate (CAGR) of 4.6% during the forecast period.
The evolving U.S. tariff policy posed substantial volatility risks to global markets. This report provides a comprehensive assessment of trade barrier escalations and cross-border counterstrategies, analyzing their multidimensional impacts on industrial competition patterns, geo-economic integration, and transnational value chain realignments.
Vertebroplasty & Kyphoplasty are minimally invasive, image guided surgical procedures performed to treat the Vertebral Compression Fracture (VCF). VCFs can lead to back pain, reduced physical activity, depression, loss of independence, decreased lung capacity, and difficulty sleeping. Bone cement is injected into the back bone (vertebra) to provide support to the broken bone. Due to osteoporosis, vascular malformatins or, less commonly, cancer fractures can be caused in the vertebra. Vertebroplasty & Kyphoplasty help the patient to regain the functional abilities and avoid further vertebral collapse. Kyphoplasty is an advanced version of Vertebroplasty which can stabilize the fracture, restore heights and reduce deformities.
The main market drivers include:
Aging population
The global population over 65 years old accounts for more than 9%, and the incidence of osteoporosis and spinal diseases is rising, which directly drives demand growth.
Technological progress
Innovative devices such as flexible vertebroplasty and intelligent balloon systems improve surgical accuracy and safety.
Biologically active bone cement (such as those containing antibiotics/growth factors) reduces the risk of infection and promotes bone healing.
Policy support
The expansion of medical insurance coverage and the tiered diagnosis and treatment policy promote the popularization of minimally invasive technology to primary medical institutions.
The government's support for domestic medical device innovation has accelerated the process of import substitution.
Market demand
Patients have an increasing demand for rapid recovery and improved quality of life, and minimally invasive surgery has become the first choice.
The number of outpatient surgery centers has increased, reducing medical costs and increasing surgical accessibility.
Emerging market potential
The Asia-Pacific region (such as China and India) is expected to account for more than 40% of the market size in 2028 due to its large population base and growing medical needs.
Domestic companies are gradually expanding their market share through cost-effective advantages and localized services.
The vertebroplasty and kyphoplasty device market has benefited from an aging population, technological advances, and policy support. It is expected that the global market size will exceed US$2.2 billion in 2028. International giants dominate the market with their technological accumulation and brand advantages, but domestic companies are gradually rising through innovation and cost advantages. In the future, with the development of bioactive materials, intelligent devices, and robot-assisted surgery, this field will evolve in a more precise, minimally invasive, and personalized direction, providing better treatment options for patients with spinal diseases around the world.
In terms of consumption side, this report focuses on the sales of Vertebroplasty and Kyphoplasty Device by region (region level and country level), by company, by Type and by Application. from 2020 to 2025 and forecast to 2031.
This report presents an overview of global market for Vertebroplasty and Kyphoplasty Device, capacity, output, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2020 - 2025, estimates for 2025, and projections of CAGR through 2031.
This report researches the key producers of Vertebroplasty and Kyphoplasty Device, also provides the consumption of main regions and countries. Highlights of the upcoming market potential for Vertebroplasty and Kyphoplasty Device, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Vertebroplasty and Kyphoplasty Device sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Vertebroplasty and Kyphoplasty Device market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Vertebroplasty and Kyphoplasty Device sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Medtronic, Stryker, Johnson & Johnson, Globus Medical, Merit Medical, IZI Medial, Kinetic Medical, Weigao Orthopedics, Dabao Medical, Shandong Dragon Crown, etc.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Vertebroplasty and Kyphoplasty Device in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Vertebroplasty and Kyphoplasty Device manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Vertebroplasty and Kyphoplasty Device sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Vertebroplasty and Kyphoplasty Device Product Introduction
1.2 Market by Type
1.2.1 Global Vertebroplasty and Kyphoplasty Device Market Size Growth Rate by Type, 2020 VS 2024 VS 2031
1.2.2 Vertebroplasty Device
1.2.3 Kyphoplasty Device
1.3 Market by Application
1.3.1 Global Vertebroplasty and Kyphoplasty Device Market Size Growth Rate by Application, 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Vertebroplasty and Kyphoplasty Device Revenue Estimates and Forecasts 2020-2031
2.2 Global Revenue by Region
2.2.1 Global Vertebroplasty and Kyphoplasty Device Revenue by Region: 2020 VS 2024 VS 2031
2.2.2 Global Vertebroplasty and Kyphoplasty Device Revenue by Region (2020-2031)
2.2.3 Global Vertebroplasty and Kyphoplasty Device Revenue Market Share by Region (2020-2031)
2.3 Global Vertebroplasty and Kyphoplasty Device Sales Estimates and Forecasts 2020-2031
2.4 Global Sales by Region
2.4.1 Global Vertebroplasty and Kyphoplasty Device Sales by Region: 2020 VS 2024 VS 2031
2.4.2 Global Vertebroplasty and Kyphoplasty Device Sales by Region (2020-2031)
2.4.3 Global Vertebroplasty and Kyphoplasty Device Sales Market Share by Region (2020-2031)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufacturers
3.1 Global Sales by Manufacturers
3.1.1 Global Vertebroplasty and Kyphoplasty Device Sales by Manufacturers (2020-2025)
3.1.2 Global Vertebroplasty and Kyphoplasty Device Sales Market Share by Manufacturers (2020-2025)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Vertebroplasty and Kyphoplasty Device in 2024
3.2 Global Revenue by Manufacturers
3.2.1 Global Vertebroplasty and Kyphoplasty Device Revenue by Manufacturers (2020-2025)
3.2.2 Global Vertebroplasty and Kyphoplasty Device Revenue Market Share by Manufacturers (2020-2025)
3.2.3 Global Top 10 and Top 5 Companies by Vertebroplasty and Kyphoplasty Device Revenue in 2024
3.3 Global Key Players of Vertebroplasty and Kyphoplasty Device, Industry Ranking, 2023 VS 2024
3.4 Global Vertebroplasty and Kyphoplasty Device Sales Price by Manufacturers (2020-2025)
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Vertebroplasty and Kyphoplasty Device Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Vertebroplasty and Kyphoplasty Device, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Vertebroplasty and Kyphoplasty Device, Product Offered and Application
3.8 Global Key Manufacturers of Vertebroplasty and Kyphoplasty Device, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Sales by Type
4.1.1 Global Vertebroplasty and Kyphoplasty Device Historical Sales by Type (2020-2025)
4.1.2 Global Vertebroplasty and Kyphoplasty Device Forecasted Sales by Type (2026-2031)
4.1.3 Global Vertebroplasty and Kyphoplasty Device Sales Market Share by Type (2020-2031)
4.2 Global Revenue by Type
4.2.1 Global Vertebroplasty and Kyphoplasty Device Historical Revenue by Type (2020-2025)
4.2.2 Global Vertebroplasty and Kyphoplasty Device Forecasted Revenue by Type (2026-2031)
4.2.3 Global Vertebroplasty and Kyphoplasty Device Revenue Market Share by Type (2020-2031)
4.3 Global Price by Type
4.3.1 Global Vertebroplasty and Kyphoplasty Device Price by Type (2020-2025)
4.3.2 Global Vertebroplasty and Kyphoplasty Device Price Forecast by Type (2026-2031)
5 Market Size by Application
5.1 Global Sales by Application
5.1.1 Global Vertebroplasty and Kyphoplasty Device Historical Sales by Application (2020-2025)
5.1.2 Global Vertebroplasty and Kyphoplasty Device Forecasted Sales by Application (2026-2031)
5.1.3 Global Vertebroplasty and Kyphoplasty Device Sales Market Share by Application (2020-2031)
5.2 Global Revenue by Application
5.2.1 Global Vertebroplasty and Kyphoplasty Device Historical Revenue by Application (2020-2025)
5.2.2 Global Vertebroplasty and Kyphoplasty Device Forecasted Revenue by Application (2026-2031)
5.2.3 Global Vertebroplasty and Kyphoplasty Device Revenue Market Share by Application (2020-2031)
5.3 Global Price by Application
5.3.1 Global Vertebroplasty and Kyphoplasty Device Price by Application (2020-2025)
5.3.2 Global Vertebroplasty and Kyphoplasty Device Price Forecast by Application (2026-2031)
6 US & Canada
6.1 US & Canada Market Size by Type
6.1.1 US & Canada Vertebroplasty and Kyphoplasty Device Sales by Type (2020-2031)
6.1.2 US & Canada Vertebroplasty and Kyphoplasty Device Revenue by Type (2020-2031)
6.2 US & Canada Market Size by Application
6.2.1 US & Canada Vertebroplasty and Kyphoplasty Device Sales by Application (2020-2031)
6.2.2 US & Canada Vertebroplasty and Kyphoplasty Device Revenue by Application (2020-2031)
6.3 US & Canada Market Size by Country
6.3.1 US & Canada Vertebroplasty and Kyphoplasty Device Revenue by Country: 2020 VS 2024 VS 2031
6.3.2 US & Canada Vertebroplasty and Kyphoplasty Device Revenue by Country (2020-2031)
6.3.3 US & Canada Vertebroplasty and Kyphoplasty Device Sales by Country (2020-2031)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Market Size by Type
7.1.1 Europe Vertebroplasty and Kyphoplasty Device Sales by Type (2020-2031)
7.1.2 Europe Vertebroplasty and Kyphoplasty Device Revenue by Type (2020-2031)
7.2 Europe Market Size by Application
7.2.1 Europe Vertebroplasty and Kyphoplasty Device Sales by Application (2020-2031)
7.2.2 Europe Vertebroplasty and Kyphoplasty Device Revenue by Application (2020-2031)
7.3 Europe Market Size by Country
7.3.1 Europe Vertebroplasty and Kyphoplasty Device Revenue by Country: 2020 VS 2024 VS 2031
7.3.2 Europe Vertebroplasty and Kyphoplasty Device Sales by Country (2020-2031)
7.3.3 Europe Vertebroplasty and Kyphoplasty Device Revenue by Country (2020-2031)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Market Size by Type
8.1.1 China Vertebroplasty and Kyphoplasty Device Sales by Type (2020-2031)
8.1.2 China Vertebroplasty and Kyphoplasty Device Revenue by Type (2020-2031)
8.2 China Market Size by Application
8.2.1 China Vertebroplasty and Kyphoplasty Device Sales by Application (2020-2031)
8.2.2 China Vertebroplasty and Kyphoplasty Device Revenue by Application (2020-2031)
9 Asia (excluding China)
9.1 Asia Market Size by Type
9.1.1 Asia Vertebroplasty and Kyphoplasty Device Sales by Type (2020-2031)
9.1.2 Asia Vertebroplasty and Kyphoplasty Device Revenue by Type (2020-2031)
9.2 Asia Market Size by Application
9.2.1 Asia Vertebroplasty and Kyphoplasty Device Sales by Application (2020-2031)
9.2.2 Asia Vertebroplasty and Kyphoplasty Device Revenue by Application (2020-2031)
9.3 Asia Market Size by Region
9.3.1 Asia Vertebroplasty and Kyphoplasty Device Revenue by Region: 2020 VS 2024 VS 2031
9.3.2 Asia Vertebroplasty and Kyphoplasty Device Revenue by Region (2020-2031)
9.3.3 Asia Vertebroplasty and Kyphoplasty Device Sales by Region (2020-2031)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
9.3.9 Australia
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Market Size by Type
10.1.1 Middle East, Africa and Latin America Vertebroplasty and Kyphoplasty Device Sales by Type (2020-2031)
10.1.2 Middle East, Africa and Latin America Vertebroplasty and Kyphoplasty Device Revenue by Type (2020-2031)
10.2 Middle East, Africa and Latin America Market Size by Application
10.2.1 Middle East, Africa and Latin America Vertebroplasty and Kyphoplasty Device Sales by Application (2020-2031)
10.2.2 Middle East, Africa and Latin America Vertebroplasty and Kyphoplasty Device Revenue by Application (2020-2031)
10.3 Middle East, Africa and Latin America Market Size by Country
10.3.1 Middle East, Africa and Latin America Vertebroplasty and Kyphoplasty Device Revenue by Country: 2020 VS 2024 VS 2031
10.3.2 Middle East, Africa and Latin America Vertebroplasty and Kyphoplasty Device Revenue by Country (2020-2031)
10.3.3 Middle East, Africa and Latin America Vertebroplasty and Kyphoplasty Device Sales by Country (2020-2031)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Corporate Profile
11.1 Medtronic
11.1.1 Medtronic Company Information
11.1.2 Medtronic Overview
11.1.3 Medtronic Vertebroplasty and Kyphoplasty Device Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.4 Medtronic Vertebroplasty and Kyphoplasty Device Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Medtronic Recent Developments
11.2 Stryker
11.2.1 Stryker Company Information
11.2.2 Stryker Overview
11.2.3 Stryker Vertebroplasty and Kyphoplasty Device Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.4 Stryker Vertebroplasty and Kyphoplasty Device Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Stryker Recent Developments
11.3 Johnson & Johnson
11.3.1 Johnson & Johnson Company Information
11.3.2 Johnson & Johnson Overview
11.3.3 Johnson & Johnson Vertebroplasty and Kyphoplasty Device Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.4 Johnson & Johnson Vertebroplasty and Kyphoplasty Device Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Johnson & Johnson Recent Developments
11.4 Globus Medical
11.4.1 Globus Medical Company Information
11.4.2 Globus Medical Overview
11.4.3 Globus Medical Vertebroplasty and Kyphoplasty Device Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.4 Globus Medical Vertebroplasty and Kyphoplasty Device Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Globus Medical Recent Developments
11.5 Merit Medical
11.5.1 Merit Medical Company Information
11.5.2 Merit Medical Overview
11.5.3 Merit Medical Vertebroplasty and Kyphoplasty Device Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.4 Merit Medical Vertebroplasty and Kyphoplasty Device Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Merit Medical Recent Developments
11.6 IZI Medial
11.6.1 IZI Medial Company Information
11.6.2 IZI Medial Overview
11.6.3 IZI Medial Vertebroplasty and Kyphoplasty Device Sales, Price, Revenue and Gross Margin (2020-2025)
11.6.4 IZI Medial Vertebroplasty and Kyphoplasty Device Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 IZI Medial Recent Developments
11.7 Kinetic Medical
11.7.1 Kinetic Medical Company Information
11.7.2 Kinetic Medical Overview
11.7.3 Kinetic Medical Vertebroplasty and Kyphoplasty Device Sales, Price, Revenue and Gross Margin (2020-2025)
11.7.4 Kinetic Medical Vertebroplasty and Kyphoplasty Device Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Kinetic Medical Recent Developments
11.8 Weigao Orthopedics
11.8.1 Weigao Orthopedics Company Information
11.8.2 Weigao Orthopedics Overview
11.8.3 Weigao Orthopedics Vertebroplasty and Kyphoplasty Device Sales, Price, Revenue and Gross Margin (2020-2025)
11.8.4 Weigao Orthopedics Vertebroplasty and Kyphoplasty Device Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Weigao Orthopedics Recent Developments
11.9 Dabao Medical
11.9.1 Dabao Medical Company Information
11.9.2 Dabao Medical Overview
11.9.3 Dabao Medical Vertebroplasty and Kyphoplasty Device Sales, Price, Revenue and Gross Margin (2020-2025)
11.9.4 Dabao Medical Vertebroplasty and Kyphoplasty Device Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Dabao Medical Recent Developments
11.10 Shandong Dragon Crown
11.10.1 Shandong Dragon Crown Company Information
11.10.2 Shandong Dragon Crown Overview
11.10.3 Shandong Dragon Crown Vertebroplasty and Kyphoplasty Device Sales, Price, Revenue and Gross Margin (2020-2025)
11.10.4 Shandong Dragon Crown Vertebroplasty and Kyphoplasty Device Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Shandong Dragon Crown Recent Developments
11.11 G21 Srl
11.11.1 G21 Srl Company Information
11.11.2 G21 Srl Overview
11.11.3 G21 Srl Vertebroplasty and Kyphoplasty Device Sales, Price, Revenue and Gross Margin (2020-2025)
11.11.4 G21 Srl Vertebroplasty and Kyphoplasty Device Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 G21 Srl Recent Developments
11.12 Spine Wave
11.12.1 Spine Wave Company Information
11.12.2 Spine Wave Overview
11.12.3 Spine Wave Vertebroplasty and Kyphoplasty Device Sales, Price, Revenue and Gross Margin (2020-2025)
11.12.4 Spine Wave Vertebroplasty and Kyphoplasty Device Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Spine Wave Recent Developments
11.13 Teknimed
11.13.1 Teknimed Company Information
11.13.2 Teknimed Overview
11.13.3 Teknimed Vertebroplasty and Kyphoplasty Device Sales, Price, Revenue and Gross Margin (2020-2025)
11.13.4 Teknimed Vertebroplasty and Kyphoplasty Device Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Teknimed Recent Developments
11.14 Biopsybell
11.14.1 Biopsybell Company Information
11.14.2 Biopsybell Overview
11.14.3 Biopsybell Vertebroplasty and Kyphoplasty Device Sales, Price, Revenue and Gross Margin (2020-2025)
11.14.4 Biopsybell Vertebroplasty and Kyphoplasty Device Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Biopsybell Recent Developments
11.15 Sanyou Medical
11.15.1 Sanyou Medical Company Information
11.15.2 Sanyou Medical Overview
11.15.3 Sanyou Medical Vertebroplasty and Kyphoplasty Device Sales, Price, Revenue and Gross Margin (2020-2025)
11.15.4 Sanyou Medical Vertebroplasty and Kyphoplasty Device Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Sanyou Medical Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Vertebroplasty and Kyphoplasty Device Industry Chain Analysis
12.2 Vertebroplasty and Kyphoplasty Device Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Vertebroplasty and Kyphoplasty Device Production Mode & Process
12.4 Vertebroplasty and Kyphoplasty Device Sales and Marketing
12.4.1 Vertebroplasty and Kyphoplasty Device Sales Channels
12.4.2 Vertebroplasty and Kyphoplasty Device Distributors
12.5 Vertebroplasty and Kyphoplasty Device Customers
13 Vertebroplasty and Kyphoplasty Device Market Dynamics
13.1 Vertebroplasty and Kyphoplasty Device Industry Trends
13.2 Vertebroplasty and Kyphoplasty Device Market Drivers
13.3 Vertebroplasty and Kyphoplasty Device Market Challenges
13.4 Vertebroplasty and Kyphoplasty Device Market Restraints
14 Key Findings in the Global Vertebroplasty and Kyphoplasty Device Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
15.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Vertebroplasty and Kyphoplasty Device market size was US$ 1163 million in 2025 and is forecast to reach a readjusted size of US$ 1587 million by 2032 with a CAGR of 4.6% during the forecast period 2026-2032.
Published Date: 2026-03-09
Pages: 99
USD 4250.00
(Single User License)
The global Vertebroplasty and Kyphoplasty Device market is projected to grow from US$ 1163 million in 2025 to US$ 1587 million by 2032, at a CAGR of 4.6% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-09
Pages: 158
USD 4900.00
(Single User License)
The global market for Vertebroplasty and Kyphoplasty Device was estimated to be worth US$ 1163 million in 2025 and is projected to reach US$ 1587 million, growing at a CAGR of 4.6% from 2026 to 2032.
Published Date: 2026-03-05
Pages: 120
USD 3950.00
(Single User License)
The global Vertebroplasty and Kyphoplasty Device market was valued at US$ 1163 million in 2025 and is anticipated to reach US$ 1587 million by 2032, at a CAGR of 4.6% from 2026 to 2032.
Published Date: 2026-03-05
Pages: 127
USD 2900.00
(Single User License)
The global Vertebroplasty and Kyphoplasty Device market is projected to grow from US$ 1063 million in 2024 to US$ 1524 million by 2031, at a CAGR of 4.6% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-10-30
Pages: 158
USD 4900.00
(Single User License)
The global Vertebroplasty and Kyphoplasty Device market size was US$ 1063 million in 2024 and is forecast to a readjusted size of US$ 1524 million by 2031 with a CAGR of 4.6% during the forecast period 2025-2031.
Published Date: 2025-09-06
Pages: 97
USD 4250.00
(Single User License)
The global market for Vertebroplasty and Kyphoplasty Device was estimated to be worth US$ 1063 million in 2024 and is forecast to a readjusted size of US$ 1524 million by 2031 with a CAGR of 4.6% during the forecast period 2025-2031.
Published Date: 2025-07-02
Pages: 111
USD 3950.00
(Single User License)
The global market for Vertebroplasty and Kyphoplasty Device was valued at US$ 1063 million in the year 2024 and is projected to reach a revised size of US$ 1524 million by 2031, growing at a CAGR of 4.6% during the forecast period.
Published Date: 2025-07-02
Pages: 91
USD 2900.00
(Single User License)
The global market for Vertebroplasty and Kyphoplasty Device was estimated to be worth US$ 1323 million in 2024 and is forecast to a readjusted size of US$ 1670 million by 2031 with a CAGR of 3.4% during the forecast period 2025-2031.
Published Date: 2025-02-25
Pages: 127
USD 3950.00
(Single User License)
Vertebroplasty & Kyphoplasty are minimally invasive, image guided surgical procedures performed to treat the Vertebral Compression Fracture (VCF). VCFs can lead to back pain, reduced physical activity, depression, loss of independence, decreased lung capacity, and difficulty sleeping. Bone cement is injected into the back bone (vertebra) to provide support to the broken bone. Due to osteoporosis, vascular malformatins or, less commonly, cancer fractures can be caused in the vertebra. Vertebroplasty & Kyphoplasty help the patient to regain the functional abilities and avoid further vertebral collapse. Kyphoplasty is an advanced version of Vertebroplasty which can stabilize the fracture, restore heights and reduce deformities. The report studies the vertebroplasty and kyphoplasty devices market.
Published Date: 2024-04-22
Pages: 111
USD 4900.00
(Single User License)
The global Vertebroplasty and Kyphoplasty Device market size was US$ 1163 million in 2025 and is forecast to reach a readjusted size of US$ 1587 million by 2032 with a CAGR of 4.6% during the forecast period 2026-2032.
Published: 2026-03-09
Pages: 99
The global Vertebroplasty and Kyphoplasty Device market is projected to grow from US$ 1163 million in 2025 to US$ 1587 million by 2032, at a CAGR of 4.6% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-09
Pages: 158
The global market for Vertebroplasty and Kyphoplasty Device was estimated to be worth US$ 1163 million in 2025 and is projected to reach US$ 1587 million, growing at a CAGR of 4.6% from 2026 to 2032.
Published: 2026-03-05
Pages: 120
The global Vertebroplasty and Kyphoplasty Device market was valued at US$ 1163 million in 2025 and is anticipated to reach US$ 1587 million by 2032, at a CAGR of 4.6% from 2026 to 2032.
Published: 2026-03-05
Pages: 127
The global Vertebroplasty and Kyphoplasty Device market is projected to grow from US$ 1063 million in 2024 to US$ 1524 million by 2031, at a CAGR of 4.6% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-10-30
Pages: 158
The global Vertebroplasty and Kyphoplasty Device market size was US$ 1063 million in 2024 and is forecast to a readjusted size of US$ 1524 million by 2031 with a CAGR of 4.6% during the forecast period 2025-2031.
Published: 2025-09-06
Pages: 97
The global market for Vertebroplasty and Kyphoplasty Device was estimated to be worth US$ 1063 million in 2024 and is forecast to a readjusted size of US$ 1524 million by 2031 with a CAGR of 4.6% during the forecast period 2025-2031.
Published: 2025-07-02
Pages: 111
The global market for Vertebroplasty and Kyphoplasty Device was valued at US$ 1063 million in the year 2024 and is projected to reach a revised size of US$ 1524 million by 2031, growing at a CAGR of 4.6% during the forecast period.
Published: 2025-07-02
Pages: 91
The global market for Vertebroplasty and Kyphoplasty Device was estimated to be worth US$ 1323 million in 2024 and is forecast to a readjusted size of US$ 1670 million by 2031 with a CAGR of 3.4% during the forecast period 2025-2031.
Published: 2025-02-25
Pages: 127
Vertebroplasty & Kyphoplasty are minimally invasive, image guided surgical procedures performed to treat the Vertebral Compression Fracture (VCF). VCFs can lead to back pain, reduced physical activity, depression, loss of independence, decreased lung capacity, and difficulty sleeping. Bone cement is injected into the back bone (vertebra) to provide support to the broken bone. Due to osteoporosis, vascular malformatins or, less commonly, cancer fractures can be caused in the vertebra. Vertebroplasty & Kyphoplasty help the patient to regain the functional abilities and avoid further vertebral collapse. Kyphoplasty is an advanced version of Vertebroplasty which can stabilize the fracture, restore heights and reduce deformities. The report studies the vertebroplasty and kyphoplasty devices market.
Published: 2024-04-22
Pages: 111
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now